Topical bevacizumab for the treatment of corneal vascularization in dogs: A case series

OBJECTIVE: To evaluate the effect and safety of topical anti‐human vascular endothelial growth factor bevacizumab in dogs with persistent corneal vascularization. ANIMALS STUDIED: Prospective case series of 15 adult dogs (20 eyes). PROCEDURES: Dogs received 0.25% bevacizumab eye drops BID for 28 day...

Descripción completa

Detalles Bibliográficos
Autores principales: Muellerleile, Lisa‐Marie, Bernkopf, Michael, Wambacher, Michael, Nell, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292418/
https://www.ncbi.nlm.nih.gov/pubmed/34487608
http://dx.doi.org/10.1111/vop.12931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292418/
https://www.ncbi.nlm.nih.gov/pubmed/34487608
http://dx.doi.org/10.1111/vop.12931

Ejemplares similares